Baxter International Inc. (BAX) will report its 2023 Q2 earnings on Thursday, 27 July 2023, before market open. Wallstreet estimates an EPS of $0.61 and a revenue of $3.80 B in the upcoming results. Historically, Baxter International Inc. beated EPS estimates 66% of the times.
About Baxter International Inc.
Baxter International Inc. develops and provides a portfolio of healthcare products worldwide. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries.